← All Sponsors
SPONSOR

Altimmune, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Alcohol Liver Disease
NCT07009860 Phase 2
Recruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Alcohol Liver Disease
United States, Puerto Rico View Trial →